Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_assertion description "[Time to HIV-1 RNA suppression below 5 copies/ml during first-line protease inhibitor-based antiretroviral treatment - any impact of residual viremia on treatment success?]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_assertion evidence source_evidence_literature NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_assertion SIO_000772 24322383 NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_assertion wasDerivedFrom befree-20150227 NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_assertion wasGeneratedBy ECO_0000203 NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP989617.RAcZGQH2uUqQ2-tHtxEvZmDYDh5q_H-dJlUFFtpI0_ioA130_provenance.